Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
244.89
-1.91 (-0.77%)
At close: Nov 22, 2024, 4:00 PM
244.40
-0.49 (-0.20%)
After-hours: Nov 22, 2024, 7:20 PM EST
Alnylam Pharmaceuticals Analyst Ratings
Total Analysts
23
Consensus Rating
Buy
Price Target
$298.59
Upside
+21.93%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $296 | Buy | Reiterates | $296 | +20.87% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $400 | Strong Buy | Reiterates | $400 | +63.34% | Nov 18, 2024 |
| Wolfe Research | Wolfe Research | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Nov 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $400 | Strong Buy | Reiterates | $400 | +63.34% | Nov 4, 2024 |
| Raymond James | Raymond James | Buy Maintains $275 → $298 | Buy | Maintains | $275 → $298 | +21.69% | Nov 1, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $300 | Buy | Reiterates | $300 | +22.50% | Nov 1, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $305 → $310 | Buy | Maintains | $305 → $310 | +26.59% | Nov 1, 2024 |
| Barclays | Barclays | Buy Maintains $295 → $329 | Buy | Maintains | $295 → $329 | +34.35% | Nov 1, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $366 → $384 | Strong Buy | Maintains | $366 → $384 | +56.81% | Nov 1, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $300 | Strong Buy | Maintains | $300 | +22.50% | Nov 1, 2024 |
| Needham | Needham | Strong Buy Reiterates $320 | Strong Buy | Reiterates | $320 | +30.67% | Nov 1, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $282 → $371 | Strong Buy | Maintains | $282 → $371 | +51.50% | Oct 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $400 | Strong Buy | Reiterates | $400 | +63.34% | Oct 18, 2024 |
| Scotiabank | Scotiabank | Buy Initiates $305 | Buy | Initiates | $305 | +24.55% | Oct 16, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $307 → $314 | Strong Buy | Maintains | $307 → $314 | +28.22% | Oct 14, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $300 | Strong Buy | Maintains | $300 | +22.50% | Oct 11, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.